![David Piacquad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Piacquad
Direktor/Vorstandsmitglied bei
NEUMORA THERAPEUTICS, INC.
Vermögen: 37 185 $ am 31.05.2026
Profil
David A. Piacquad is currently an Independent Director at Angitia Biopharmaceuticals Guangzhou Ltd. and an Independent Director at Neumora Therapeutics, Inc. since 2023.
Former positions include Senior VP-Business Development & Licensing at Schering-Plough Corp.
from 2006 to 2009, Vice President-Licensing & Acquisitions at McNeil Consumer & Specialty Pharmaceuticals, Inc., Vice President-Ventures & Business Development at Johnson & Johnson, Inc., Principal at Mr. Piacquad Consulting LLC in 2010, and Senior Vice President-Business Development at Amgen, Inc. from 2014 to 2022.
Education includes an undergraduate degree from Colgate University and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.05.2026 | 20.100 ( 0,01 % ) | 37 185 $ | 31.05.2026 |
Aktive Positionen von David Piacquad
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2023 |
Angitia Biopharmaceuticals Guangzhou Ltd.
 Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Piacquad
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01.02.2022 |
David A. Piacquad Consulting LLC | Corporate Officer/Principal | 01.06.2010 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.12.2009 |
Johnson & Johnson, Inc.
 Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Corporate Officer/Principal | - |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
 McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Corporate Officer/Principal | - |
Ausbildung von David Piacquad
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Health Technology |
Johnson & Johnson, Inc.
Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Operates as an independent wholesale insurance brokerage company | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David A. Piacquad Consulting LLC | |
Angitia Biopharmaceuticals Guangzhou Ltd.
Angitia Biopharmaceuticals Guangzhou Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on discovering and developing biologic therapies for musculoskeletal diseases | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
